急性淋巴细胞白血病的CAR-T细胞疗法
Wednesday 星期三, 24-11-2021 | 17:00 - 18:00 ( UTC+8 | SGT )
AGENDA
SYNOPSIS
For parents, coping and caring for a child with acute lymphoblastic leukemia (ALL) can be challenging, including the choice of treatments such as chemotherapy, radiation therapy, surgery and bone marrow transplantation. Though these treatments are useful, they are not always successful and could result in many long-term side effects. Recently, chimeric antigen receptor modified T cells (CAR-T) become a new form of treatment for ALL. In this webinar, Dr. Chan,Dr Leung and Dr Li will share practical information with patients, survivors, their family members and caregivers on CAR-T Therapy and how it can save more children with ALL with less side effects.
应对和照顾患有急性淋巴细胞白血病（ALL）的孩子，对父母是一项艰巨的挑战，包括该选择化疗、放射治疗、手术还是骨髓移植等治疗方案？这些虽然是有效的治疗方案，但未必适用于每个病童，并且可能导致许多长期的副作用。嵌合抗原受体修饰T细胞（CAR-T）是近期治疗ALL的一种新方案。在本次网络研讨会上，梁医生，陈医生和李医生将与患者、康复者、他们的家人和护理人员分享有关CAR-T治疗的实用信息，以及它如何能够以较少的副作用挽救更多患有 ALL 的儿童。
Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
WATCH IT AGAIN!
SPEAKERS
Dr Wing Leung
梁永恆医生
Head of Department
Clinical Professor
Department of Paediatrics and Adolescent Medicine
LKS Faculty of Medicine
The University of Hong Kong
Professor Wing Leung, MBBS PhD, is a Senior Consultant in Hematology and Oncology at KK Women’s and Children’s Hospital and a Professor at Duke-NUS Medical School in Singapore. He is the Chair of the TCL-CCF Professorship and the Director of Pediatric Bone Marrow Transplant and Cellular Therapy Center. Previously, he was the Chair of the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital and Vice President of Clinical Development at Miltenyi Biotec. Prof. Leung obtained his medical degree from the University of Hong Kong and a Ph.D. from the Johns Hopkins University. He is a diplomate certified in general pediatrics and in pediatric hematology-oncology by the American Board of Pediatrics. Prof. Leung has a major research interest in the biology of human natural killer cells and memory T cells, specifically the clinical applications in hematopoietic stem cell transplantation and cellular therapy. His research received continuous funding from the National Institutes of Health. He is an elected Member of the American Society for Clinical Investigation.
Dr Godfrey Chan
陈志峰医生
Clinical Professor
Tsao Yen-Chow Endowed Professor in Paediatrics and Adolescent Medicine
Department of Paediatrics and Adolescent Medicine
LKS Faculty of Medicine, The University of Hong Kong
Chief of Service
Department of Paediatrics and Adolescent Medicine,
Hong Kong Children's Hospital / HKU-Shenzhen Hospital / Gleneagles Hospital
Prof. Chan graduated from Dentistry (DMD, Cum Laude & Valedictorian 1981) and Medicine (MD, 1985) respectively from University of the East, Philippines and is currently both a registered dentist and medical doctor in Hong Kong. He joined the Department of Pediatrics of the University of Hong Kong in 1989. Then he pursued further training at the St. Jude Children’s Research Hospital, USA as a fellow from 1993 to 1996. He then obtained Dip of Palliative Medicine (1997) from University of Wales and MSc from University of Birmingham (1999). He joined the Faculty of Medicine, University of Hong Kong as Clinical Associate Professor in 1999, and was appointed as the Assistant Dean (External Affair) of the LKS Faculty of Medicine from 2004 to 2013. He was promoted to Clinical Professor in 2009. Since 2012, he has been the Head & Chief of Service of the Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital & HKU-Shenzhen Hospital, The University of Hong Kong. He was awarded Tsao Yen-Chow Endowed Professorship of Pediatrics & Adolescent Medicine in 2013. He is currently the Director of the Molecular Laboratory for Traditional Chinese Medicine, HKU. He has recently been appointed as the Chief of Service and Service Head of Pediatric Oncology for The Hong Kong Children’s Hospital since Oct 2018. He supervised >50 MSc & PhD students and published >300 full articles, 10 book chapters and 1 book. He serves as editor for 12 journals and is the immediate past Chief Editor of Hong Kong Journal of Paediatrics. He received multiple prestigious research grants with a total amount over US$ 6millions. He owned 5 patents including 3 on collagen microsphere device for the delivery of human mesenchymal stem cells. He has multiple International Awards (ANR, SIOP, ASPR, Endeavor Executive Award-Australian Government, Outstanding Pediatrician of APPA) for his clinical and laboratory research works on childhood neurogenic tumors and stem cells biology. His research interest includes the immunological aspects of stem cells, cancers and thalassemia. He is the Immediate Past Chairman of St Jude-VIVA-Asia Pediatric BMT Consortium, Regional Chairman (Asia, Australia & Africa) of Advance in Neuroblastoma Research, Secretary of the Asian Pediatric Hematology Oncology Group, and was the President of Hong Kong Pediatric Society.
Dr Benshang Li
李本尚医生
Chief physician of the Department of Hematology&Oncology and Director of Clinical Hematology Oncology Laboratory
上海儿童医学中心血液肿瘤科主任医师，临床血液肿瘤实验室主任
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
上海交通大学医学院附属上海儿童医学中心
上海儿童医学中心血液肿瘤科副主任，临床血液肿瘤实验室主任，国家卫健委儿童血液肿瘤重点实验室PI。目前为中国医师协会临床遗传学、免疫学组委员，中华医学会儿科学分会精准医学专业委员会委员。擅长儿童血液肿瘤疾病微量残留病的检测和监测，疑难和罕见血液系统疾病的分子诊断和血液肿瘤疾病的CAR-T细胞治疗。先后参与和主持了多项国家自然科学基金、上海市科委科研基金、上海市卫生局科研基金、上海交通大学科研基金、中国博士后研究基金等课题的研究工作。主要从事白血病基因组学研究和CAR-T治疗技术研究。
